Vitamin D Levels are Associated with Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity
High prevalence of low vitamin D levels is associated with increased disease severity due to an increased immune-inflammatory response.
High prevalence of low vitamin D levels is associated with increased disease severity due to an increased immune-inflammatory response.
Though the results are not significant, Serum levels of 25(OH)D, vitamin B12, and especially zinc at the time of admission can affect clinical outcomes in COVID‐19 patients.
Vitamin D deficiency has a significant dose-response relationship with adverse clinical outcomes of COVID-19 infection, including hospitalization and mortality.
Vitamin D levels of healthy children (>6 years old) and adolescents decreased in the first year of the pandemic most likely due to the pandemic-related restrictions.
Vitamin D and COVID-19 Infection Take Home Message Vitamin D deficiency
Does vitamin D serum level affect prognosis of COVID-19 patients? Take Home
Vitamin D deficiency in critically ill COVID-19 ARDS patients Take Home Message
Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths:
Detectable respiratory SARS-CoV-2 RNA is associated with low vitamin D levels and high
Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age
